BioSpace News Archive

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), today announced that new preclinical data for EDP-235, its lead oral coronavirus protease inhibitor specifically designed for the treatment of COVID-19, will be presented at IDWeek 2022 being held October 19 – 23, 2022 in Washington, DC.

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting at Baird’s 2022 Global Healthcare Conference taking place September 13-14, 2022, at the InterContinental New York Barclay Hotel.

Lutris Pharma, today announced positive top-line results from the open label part 1 and double blinded part 2 of its phase 1/2 trial of lead compound, LUT014, a topically applied, novel B-Raf inhibitor, for the treatment of radiation-induced dermatitis (RD) in patients with breast cancer.

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), today announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals, will present at the H.C. Wainwright 24th Annual Global Investment Conference being held in New York, NY and virtually on September 12-14, 2022.

Vektor Medical, the developer of the world’s first technology to rapidly map cardiac arrhythmias using only 12-lead ECG data, today announced Circulation: Arrhythmia and Electrophysiology has published a peer-reviewed manuscript of the clinical data from a study evaluating the accuracy of its vMap® technology.

TearLab® Corporation, the global leader in ophthalmic point-of-care diagnostics, announced that it will be expanding its position in corneal health under the new name Trukera™ Medical.

Visus Therapeutics, Inc. announced that Ben Bergo, co-founder and chief executive officer, will present at the Baird 2022 Global Healthcare Conference on September 13th, 2022, at the InterContinental New York Barclay hotel.

Serpex Medical announced today U.S. FDA 510(k) clearance of its Compass Steerable Needles – steerable biopsy needles that enable precise access to lung nodules in the intrapulmonary region.

Biosion, Inc. announced the appointment of Rakesh Dixit, Ph.D., DABT to its Advisory Board to advance Antibody Drug-Conjugates for the treatment of solid tumor cancers in Biosion’s pipeline.

INmune Bio (NASDAQ: INMB), announced today that RJ Tesi, M.D., Chief Executive Officer will present a corporate overview at the H.C. Wainwright 24th Annual Global Investment Conference being held on September 12 - 14, 2022, and the Baird Global Healthcare Conference being held on September 13 – 14, 2022.